Egypt Neuraminidase Inhibitors Market (2025-2031) | Industry, Size & Revenue, Outlook, Value, Companies, Trends, Competitive Landscape, Analysis, Share, Segmentation, Growth, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Egypt Country Macro Economic Indicators

3.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Egypt Neuraminidase Inhibitors Market - Industry Life Cycle

3.4 Egypt Neuraminidase Inhibitors Market - Porter's Five Forces

3.5 Egypt Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Egypt Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Egypt Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Egypt Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Egypt Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the benefits of neuraminidase inhibitors in treating influenza.

4.2.2 Growing prevalence of influenza cases in Egypt.

4.2.3 Favorable government initiatives to promote the adoption of neuraminidase inhibitors.

4.3 Market Restraints

4.3.1 High cost associated with neuraminidase inhibitors.

4.3.2 Limited access to advanced healthcare facilities in certain regions of Egypt.

4.3.3 Concerns regarding potential side effects of neuraminidase inhibitors.

6.1 Egypt Neuraminidase Inhibitors Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F

6.1.4 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F

6.1.5 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Egypt Neuraminidase Inhibitors Market, By Product

6.2.1 Overview and Analysis

6.2.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F

6.2.3 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F

6.2.4 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F

6.2.5 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F

6.2.6 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F

6.3 Egypt Neuraminidase Inhibitors Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F

6.3.4 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.5 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Egypt Neuraminidase Inhibitors Market, By End User

6.4.1 Overview and Analysis

6.4.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Egypt Neuraminidase Inhibitors Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Egypt Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Egypt Neuraminidase Inhibitors Market Export to Major Countries

7.2 Egypt Neuraminidase Inhibitors Market Imports from Major Countries

8.1 Patient adherence rate to neuraminidase inhibitors treatment.

8.2 Number of healthcare facilities offering neuraminidase inhibitors.

8.3 Rate of prescriptions for neuraminidase inhibitors compared to other influenza treatments.

9.1 Egypt Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Egypt Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Egypt Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Egypt Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Egypt Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Egypt Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024

10.2 Egypt Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters